IPV

From the Knowledge Hub

Author: Anand Anbarasu, Paul Livingstone, Sudha Ramaiah, Reetika Debroy, Gayathri Ashok, Soumya Basu

September 2018 VIEW-hub Report: Global Vaccine Introduction and Implementation

Author: Ibrahim Dadari, Niklas Danielsson, Rachel V. Belt, Samir V. Sodha, Ananya Iyengar, Arindam Ray, Iqbal Hossain, Daniel Ali

June 2018 VIEW-hub Report on Global Introduction and Implementation

Author: Kirsten Ward

Report from the Seventeenth Meeting Global Commission for the Certification of the Eradication of Poliomyelitis

Author: UNICEF, World Health Organization (WHO)

Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the NanopatchTM Microprojection Array

December 2017 VIEW-hub Report on Global Introduction and Implementation

Author: World Health Organization (WHO)

Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio

Author: Chifuniro Chiyendausiku, Rebecca Alban, Tafwirapo Chihana

Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes

Author: The ROTA Council

Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission

Author: World Health Organization (WHO)

Monitoring and Validation of the Global Replacement of tOPV with bOPV, April–May 2016

Administering Multiple Injectable Vaccines During a Single Visit—Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine Globally

Author: Noni MacDonald, Dalhousie U.

Acceptance of the Administration of Multiple Injectable Vaccines in a Single Immunization Visit in Albania

Author: Lee Hall

Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria

Author: World Health Organization (WHO)

Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April–November 2015

Author: World Health Organization (WHO)

Cold-Chain Adaptability During Introduction of Inactivated Polio Vaccine in Bangladesh, 2015

The Role of National Immunization Technical Advisory Groups (NITAGs) in the Introduction of Inactivated Polio Vaccine: Experience of the Indonesia and Uganda NITAGs

Author: Laura Nic Lochlainn

Experience With Inactivated Polio Vaccine Introduction and the “Switch” From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization’s Western Pacific Region

Author: Barney Graham

The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region

Author: Charlie Weller

Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region

Author: Peter Dull, Sinead Delany-Moretlwe

June 2017 VIEW-hub Report on Global Introduction and Implementation

Author: Abdul Momin Kazi

Exceptional financial support for introduction of Inactivated Polio Vaccine in middle-income countries

Author: Shahida Baqar, Alejandro Cravioto

Managing the planned cessation of a global supply market: Lessons learned from the global cessation of the trivalent Oral Poliovirus Vaccine market

Author: Philippe-Alexandre Gilbert

A supply and demand management perspective on the accelerated global introductions of Inactivated Poliovirus Vaccine in a constrained supply market

Author: Raman Rao, Jessica Martinez

Communications, immunization, and polio vaccines: Lessons from a global perspective on generating political will, informing decision-making and planning, and engaging local support

Author: Melanie Saville

Lessons learned from managing the planning and implementation of inactivated polio vaccine introduction in support of the polio endgame

Author: Annie Mo, Jerome Kim

Polio endgame: Lessons learned from the Immunization Systems Management Group

Author: Martin Friede

Progress toward containment of poliovirus Type 2 — worldwide, 2017

Author: Max Silverman, Sue Ann Clemens

VIEW-hub Report

Author: Carolyn Deal, Ruth Karron

First-in-human safety and immunogenicity investigations of 3 adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster to adolescents with a history of IPV vaccination

Author: World Health Organization (WHO)

Guidance for assessment of poliovirus vaccination status and vaccination of children who have received poliovirus vaccine outside the United States

Author: Mathias Garny

Wild and vaccine-derived poliovirus circulation, and implications for polio eradication

Author: Melkamu Ayalew

Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants

Author: VillageReach

Polio endgame, information gaps related to vaccines and immunity

Author: VillageReach

India's preparedness for introduction of IPV and switch from tOPV to bOPV

Author: VillageReach

September 2016 VIEW-hub Report on Global Introduction and Implementation

Author: VillageReach

Population immunity against serotype-2 poliomyelitis leading up to the global withdrawal of the oral poliovirus vaccine: Spatio-temporal modelling of surveillance data

Author: VillageReach

The need and potential of Inactivated Poliovirus Vaccine

Author: VillageReach

Fractional-dose inactivated poliovirus vaccination campaign, Telangana state, India, June 2016

Author: Chang-Yuil Kang

June 2016 VIEW-hub Report on Global Introduction and Implementation

Author: Timothy Chege

The importance of social networking in a national polio vaccine Campaign

Author: Josphat Kiprop Kosgei

Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial

Author: Chul Kim

The potential impact of routine immunization with inactivated poliovirus vaccine on wild-type or Vaccine-derived Poliovirus Outbreaks in a post-eradication setting

Author: Dal-Hee Min

Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities — Kenya, December 2013

Author: Mohammad Mamun Alam

afety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP–IPV) vaccine

Author: Debasu Damtie

Making history: from a public health emergency to a polio-free world

Author: Hitt Sharma

Circulating vaccine-derived poliovirus outbreaks in 5 countries, 2014–2015

Author: Peter Dull

Priming after a fractional dose of inactivated poliovirus vaccine

Author: Michelo Simuyandi

The effect of mass immunisation campaigns and new oral poliovirus vaccines of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis

Author: Ruth Karron

Polio in Nigeria: The race to eradication

Author: Annelies Wilder-Smith

Inactivated polio vaccine and global polio eradication

Author: Jessica Fleming

Why is Pakistan a threat to ‘‘The Polio Eradication and Endgame Strategic Plan 2013–2018’’? A look into the past decade

Author: Cathy Ndiaye

The last mile in global poliomyelitis eradication

Author: Halidou Tinto

A worldwide shift in polio vaccines for routine immunisation

Author: Alexander Rowe

Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial

Author: Hani Kim

Introduction of inactivated poliovirus vaccine and switch from trivalent to bivalent oral poliovirus vaccine — Worldwide, 2013–2016

Author: Alice Chen

Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants

Author: Peter Andersen

The budget impact of controlling wastage with smaller vials: A data driven model of session sizes in Bangladesh, India (Uttar Pradesh), Mozambique, and Uganda

Author: Darin Edwards

The challenge of changing the inactivated poliomyelitis vaccine in Latin America. Declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE)

Author: Chunlin Xin

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies

Author: Michael Egan

Alternative delivery of a thermostable inactivated polio vaccine

Author: Peter Openshaw

Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study

Author: Melanie Saville

Introduction of inactivated polio vaccine and specific determinants of vaccine hesitancy

Author: Melanie Saville

Case Studies of IPV introduction: Albania, Nigeria, and Tunisia

Author: Nathalie Garcon

Page 1/14

Browse the Knowledge Hub

Technet-21 Members

You must be logged in to see other members.

Upcoming events

No upcoming events.

Recent forum posts

No recent forum posts found.

Visit the Forum

Careers

No careers found.

Partner news

No Blog entries found.

Hot Topics

No Hot Topics found.

View all Hot Topics

Tags

From the Knowledge Hub

Technet-21 Members

Upcoming events

Recent forum posts

Careers

Partner news

Hot Topics

About

Knowledge Hub

Community

More